DE69706146D1 - Taxoide, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen - Google Patents

Taxoide, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen

Info

Publication number
DE69706146D1
DE69706146D1 DE69706146T DE69706146T DE69706146D1 DE 69706146 D1 DE69706146 D1 DE 69706146D1 DE 69706146 T DE69706146 T DE 69706146T DE 69706146 T DE69706146 T DE 69706146T DE 69706146 D1 DE69706146 D1 DE 69706146D1
Authority
DE
Germany
Prior art keywords
taxoids
production
pharmaceutical compositions
compositions containing
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69706146T
Other languages
English (en)
Other versions
DE69706146T2 (de
Inventor
Herve Bouchard
Jean-Dominique Bourzat
Alain Commercon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Publication of DE69706146D1 publication Critical patent/DE69706146D1/de
Application granted granted Critical
Publication of DE69706146T2 publication Critical patent/DE69706146T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/06—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69706146T 1996-03-06 1997-03-05 Taxoide, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen Expired - Fee Related DE69706146T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9602804A FR2745814B1 (fr) 1996-03-06 1996-03-06 Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
PCT/FR1997/000386 WO1997032869A1 (fr) 1996-03-06 1997-03-05 Taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
DE69706146D1 true DE69706146D1 (de) 2001-09-20
DE69706146T2 DE69706146T2 (de) 2002-05-02

Family

ID=9489910

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69706146T Expired - Fee Related DE69706146T2 (de) 1996-03-06 1997-03-05 Taxoide, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen

Country Status (34)

Country Link
US (1) US6160135A (de)
EP (1) EP0885208B1 (de)
JP (1) JP2000506158A (de)
KR (1) KR19990087398A (de)
CN (1) CN1210525A (de)
AP (1) AP1023A (de)
AT (1) ATE204266T1 (de)
AU (1) AU715228B2 (de)
BG (1) BG63693B1 (de)
BR (1) BR9707887A (de)
CA (1) CA2248195A1 (de)
CZ (1) CZ283498A3 (de)
DE (1) DE69706146T2 (de)
DK (1) DK0885208T3 (de)
EA (1) EA001516B1 (de)
EE (1) EE03611B1 (de)
ES (1) ES2161446T3 (de)
FR (1) FR2745814B1 (de)
GE (1) GEP20012517B (de)
GR (1) GR3036410T3 (de)
HU (1) HUP9902425A3 (de)
IL (1) IL125998A (de)
IS (1) IS4809A (de)
NO (1) NO983472D0 (de)
NZ (1) NZ331040A (de)
OA (1) OA10855A (de)
PL (1) PL328691A1 (de)
PT (1) PT885208E (de)
SK (1) SK121598A3 (de)
TR (1) TR199801732T2 (de)
TW (1) TW474928B (de)
WO (1) WO1997032869A1 (de)
YU (1) YU38398A (de)
ZA (1) ZA971746B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5973160A (en) 1992-12-23 1999-10-26 Poss; Michael A. Methods for the preparation of novel sidechain-bearing taxanes
MA23823A1 (fr) 1995-03-27 1996-10-01 Aventis Pharma Sa Nouveaux taxoides, leur preparation et les compositions qui les contiennent
US6372780B2 (en) 1995-03-27 2002-04-16 Aventis Pharma S.A. Methods of treating cell lines expressing multidrug resistance P-glycoprotein
CA2314071A1 (en) * 1997-12-19 1999-07-01 Kabushiki Kaisha Yakult Honsha Taxane derivatives
EP1020188A1 (de) * 1999-01-13 2000-07-19 Aventis Pharma S.A. Neue Verwendung von Taxoid-Derivaten
CO5280224A1 (es) * 2000-02-02 2003-05-30 Univ Florida State Res Found Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen
MXPA01009902A (es) 2000-02-02 2003-07-28 Univ Florida State Res Found Taxanos sustituidos con carbonato en c10 como agentes antitumor.
FR2859996B1 (fr) * 2003-09-19 2006-02-03 Aventis Pharma Sa Solvat acetonique du dimethoxy docetaxel et son procede de preparation
SV2006002036A (es) 2004-03-05 2006-03-16 Univ Florida State Res Found Taxanos con sustituyente lactiloxilo en el c7
CN101835769A (zh) * 2007-08-22 2010-09-15 6570763加拿大有限公司 将9-二氢-13-乙酰基浆果赤霉素ⅲ转化为多烯紫杉醇或太平洋紫杉醇的方法
FR2926551A1 (fr) * 2008-01-17 2009-07-24 Aventis Pharma Sa Formes cristallines du dimethoxy docetaxel et leurs procedes de preparation
EP2493466B1 (de) 2009-10-29 2021-03-10 Sanofi Mature IP Neue antitumorale verwendung von cabazitaxel
CN104650012A (zh) * 2013-11-22 2015-05-27 天士力控股集团有限公司 一种紫杉烷类化合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5136060A (en) * 1989-11-14 1992-08-04 Florida State University Method for preparation of taxol using an oxazinone
CA2092705C (en) * 1991-07-17 1995-11-07 Koji Saito Compound having antitumor activity, nsc-lsc1, and process for producing the same
CA2100808A1 (en) * 1992-10-01 1994-04-02 Vittorio Farina Deoxy paclitaxels
ATE284689T1 (de) * 1993-03-22 2005-01-15 Univ Florida State Pharmazeutische zusammenstellungen enthaltende eine furyl oder thienyl substituierte seitenkette
FR2711369B1 (fr) * 1993-10-20 1995-11-17 Rhone Poulenc Rorer Sa Nouveaux taxoïdes, leur préparation et les compositions qui les contiennent.
CZ293076B6 (cs) * 1994-07-26 2004-02-18 Indena S. P. A. Polosyntetické taxany, způsob jejich výroby, farmaceutické prostředky s jejich obsahem a meziprodukty pro jejich výrobu
US6201140B1 (en) * 1994-07-28 2001-03-13 Bristol-Myers Squibb Company 7-0-ethers of taxane derivatives

Also Published As

Publication number Publication date
IL125998A0 (en) 1999-04-11
KR19990087398A (ko) 1999-12-27
BG63693B1 (bg) 2002-09-30
EE9800264A (et) 1999-02-15
AU715228B2 (en) 2000-01-20
IL125998A (en) 2002-02-10
EP0885208A1 (de) 1998-12-23
FR2745814B1 (fr) 1998-04-03
AP1023A (en) 2001-11-16
EP0885208B1 (de) 2001-08-16
CZ283498A3 (cs) 1999-01-13
HUP9902425A3 (en) 2001-08-28
WO1997032869A1 (fr) 1997-09-12
JP2000506158A (ja) 2000-05-23
BG102753A (en) 1999-09-30
OA10855A (fr) 2003-02-05
EA001516B1 (ru) 2001-04-23
US6160135A (en) 2000-12-12
GR3036410T3 (en) 2001-11-30
PL328691A1 (en) 1999-02-15
CA2248195A1 (fr) 1997-09-12
EE03611B1 (et) 2002-02-15
AP9801335A0 (en) 1998-09-30
FR2745814A1 (fr) 1997-09-12
CN1210525A (zh) 1999-03-10
TR199801732T2 (xx) 1998-12-21
ZA971746B (en) 1997-09-16
PT885208E (pt) 2001-11-30
BR9707887A (pt) 1999-09-21
HUP9902425A2 (hu) 2001-04-28
DE69706146T2 (de) 2002-05-02
GEP20012517B (en) 2001-08-27
NZ331040A (en) 2000-02-28
AU2030297A (en) 1997-09-22
ATE204266T1 (de) 2001-09-15
DK0885208T3 (da) 2001-10-15
SK121598A3 (en) 1999-01-11
TW474928B (en) 2002-02-01
IS4809A (is) 1998-07-24
NO983472L (no) 1998-07-28
ES2161446T3 (es) 2001-12-01
YU38398A (sh) 1999-07-28
NO983472D0 (no) 1998-07-28
EA199800795A1 (ru) 1999-02-25

Similar Documents

Publication Publication Date Title
ATE188471T1 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzung
DE69928260D1 (de) Schwefel-substituierte sulfonylaminocarbonsäure n-arylamide, ihre herstellung, ihre anwendung und diese enthaltende pharmazeutische zusammensetzungen
DE69630145D1 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
ATE478840T1 (de) 3-aminoazetidinderivate enthaltende pharmazeutische zusammensetzungen, diese derivate und deren herstellung
ATE432919T1 (de) Azetidinderivate, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen
EE200000468A (et) Ühendid, nende kasutamine ja farmatseutiline kompositsioon
DK0747050T4 (da) Farmaceutiske sammensætninger, der indeholder irbesartan
DE59905572D1 (de) Substituierte 4-amino-2-aryl-pyrimidine, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate
KR100547921B1 (ko) 설폰아미드-치환된크로만,이의제조방법및이를포함하는약제학적조성물
DE69715009T2 (de) Substituierte thiazolidinedione derivate, ihre herstellung und pharmazeutische zusammensetzungen, die sie enthalten
DE69608680T2 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
DE69706146D1 (de) Taxoide, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE69610085T2 (de) Taxol derivate,deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
ATE252096T1 (de) Prolylendopeptidase-inhibitoren, ihre herstellung und ihre pharmazeutische verwendung
FR2721023B1 (fr) Nouveaux Taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
DE69614568T2 (de) Neue taxoide, herstellung und pharmazeutische zusammensetzungen diese enthaltend
DE69509621T2 (de) Diarylheptanoidderivat und diese enthaltende pharmazeutische Zusammensetzung
DE60005337D1 (de) Spiroimidazolidinderivate, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate
ATE157360T1 (de) Thienocyclopentanonoximether, ihre herstellung und diese enthaltende arzneimittel
FR2721026B1 (fr) Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
FR2721025B1 (fr) Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
TR199500776A2 (tr) Farmasötik bilesimler.
BR9603253B1 (pt) derivado de camptotecina e composiÇço farmacÊutica compreendendo o mesmo.
ATE77820T1 (de) Substituierte tetrahydroisochinolin-verbindungen, ihre herstellung und diese enthaltende pharmazeutische mittel.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee